KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cost of Revenue: 2009-2014

Historic Cost of Revenue for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $121,000.

  • Biocryst Pharmaceuticals' Cost of Revenue was N/A to $1.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $121,000 for FY2014, which is 23.47% up from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Cost of Revenue is $121,000, which was up 23.47% from $98,000 recorded in FY2013.
  • Biocryst Pharmaceuticals' Cost of Revenue's 5-year high stood at $132,000 during FY2012, with a 5-year trough of $86,000 in FY2010.
  • Moreover, its 3-year median value for Cost of Revenue was $121,000 (2014), whereas its average is $117,000.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Cost of Revenue slumped by 98.11% in 2010, and later rose by 23.47% in 2014.
  • Over the past 4 years, Biocryst Pharmaceuticals' Cost of Revenue (Yearly) stood at $86,000 in 2010, then reached $132,000 in 2012, then dropped by 25.76% to $98,000 in 2013, then climbed by 23.47% to $121,000 in 2014.